Recent Advances in the Development of Tetrazine Ligation Tools for Pretargeted Nuclear Imaging

Overview

Journal Pharmaceuticals (Basel)

Publisher MDPI

Specialty Chemistry

Date 2022 Jun 24

PMID 35745604

Authors

Rocio Garcia-Vazquez

Umberto Maria Battisti

Matthias M Herth

Affiliations

Soon will be listed here.

Abstract

Tetrazine ligation has gained interest as a bio-orthogonal chemistry tool within the last decade. In nuclear medicine, tetrazine ligation is currently being explored for pretargeted approaches, which have the potential to revolutionize state-of-the-art theranostic strategies. Pretargeting has been shown to increase target-to-background ratios for radiopharmaceuticals based on nanomedicines, especially within early timeframes. This allows the use of radionuclides with short half-lives which are more suited for clinical applications. Pretargeting bears the potential to increase the therapeutic dose delivered to the target as well as reduce the respective dose to healthy tissue. Combined with the possibility to be applied for diagnostic imaging, pretargeting could be optimal for theranostic approaches. In this review, we highlight efforts that have been made to radiolabel tetrazines with an emphasis on imaging.

Citing Articles

Development of Polar BODIPY-Tetrazines for Rapid Pretargeted Fluorescence Imaging.

Staudt M, Hvass L, Muller M, Garcia-Vazquez R, Jo Rgensen J, Shalgunov V ACS Omega. 2024; 9(41):42498-42505.

PMID: 39431101 PMC: 11483389. DOI: 10.1021/acsomega.4c06570.

Development of a 99mTc-labeled tetrazine for pretargeted SPECT imaging using an alendronic acid-based bone targeting model.

Bohrmann L, Poulie C, Rodriguez-Rodriguez C, Karagiozov S, Saatchi K, Herth M PLoS One. 2024; 19(4):e0300466.

PMID: 38626058 PMC: 11020896. DOI: 10.1371/journal.pone.0300466.

Synthesis and evaluation of fluorine-18 labelled tetrazines as pre-targeting imaging agents for PET.

Schlein E, Rokka J, Odell L, Lopes van den Broek S, Herth M, Battisti U EJNMMI Radiopharm Chem. 2024; 9(1):21.

PMID: 38446356 PMC: 10917718. DOI: 10.1186/s41181-024-00250-6.

Click Reactions in Medicinal Chemistry.

Bosc D Pharmaceuticals (Basel). 2023; 16(10).

PMID: 37895832 PMC: 10610155. DOI: 10.3390/ph16101361.

Synthesis, Fluorine-18 Radiolabeling, and In Vivo PET Imaging of a Hydrophilic Fluorosulfotetrazine.

Beaufrez J, Guillouet S, Seimbille Y, Perrio C Pharmaceuticals (Basel). 2023; 16(5).

PMID: 37242419 PMC: 10221973. DOI: 10.3390/ph16050636.

References

Delso G, Ziegler S . PET/MRI system design. Eur J Nucl Med Mol Imaging. 2008; 36 Suppl 1:S86-92. DOI: 10.1007/s00259-008-1008-6. View

Ackerman M, Chalouni C, Schmidt M, Raman V, Ritter G, Old L . A33 antigen displays persistent surface expression. Cancer Immunol Immunother. 2008; 57(7):1017-27. PMC: 2836164. DOI: 10.1007/s00262-007-0433-x. View

Devaraj N, Weissleder R . Biomedical applications of tetrazine cycloadditions. Acc Chem Res. 2011; 44(9):816-27. PMC: 3166440. DOI: 10.1021/ar200037t. View

Nichols B, Qin Z, Yang J, Vera D, Devaraj N . 68Ga chelating bioorthogonal tetrazine polymers for the multistep labeling of cancer biomarkers. Chem Commun (Camb). 2014; 50(40):5215-5217. PMC: 4119763. DOI: 10.1039/c3cc49530b. View

Jacobson O, Kiesewetter D, Chen X . Fluorine-18 radiochemistry, labeling strategies and synthetic routes. Bioconjug Chem. 2014; 26(1):1-18. PMC: 4306521. DOI: 10.1021/bc500475e. View

Piel M, Vernaleken I, Rosch F . Positron emission tomography in CNS drug discovery and drug monitoring. J Med Chem. 2014; 57(22):9232-58. DOI: 10.1021/jm5001858. View

Sletten E, Bertozzi C . Bioorthogonal chemistry: fishing for selectivity in a sea of functionality. Angew Chem Int Ed Engl. 2009; 48(38):6974-98. PMC: 2864149. DOI: 10.1002/anie.200900942. View

Miller P, Long N, Vilar R, Gee A . Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography. Angew Chem Int Ed Engl. 2008; 47(47):8998-9033. DOI: 10.1002/anie.200800222. View

Stockhofe K, Postema J, Schieferstein H, Ross T . Radiolabeling of Nanoparticles and Polymers for PET Imaging. Pharmaceuticals (Basel). 2014; 7(4):392-418. PMC: 4014699. DOI: 10.3390/ph7040392. View

10.

Svatunek D, Denk C, Mikula H . A computational model to predict the Diels-Alder reactivity of aryl/alkyl-substituted tetrazines. Monatsh Chem. 2018; 149(4):833-837. PMC: 5906496. DOI: 10.1007/s00706-017-2110-x. View

11.

Deng X, Rong J, Wang L, Vasdev N, Zhang L, Josephson L . Chemistry for Positron Emission Tomography: Recent Advances in C-, F-, N-, and O-Labeling Reactions. Angew Chem Int Ed Engl. 2018; 58(9):2580-2605. PMC: 6405341. DOI: 10.1002/anie.201805501. View

12.

Pretze M, Pietzsch D, Mamat C . Recent trends in bioorthogonal click-radiolabeling reactions using fluorine-18. Molecules. 2013; 18(7):8618-65. PMC: 6270032. DOI: 10.3390/molecules18078618. View

13.

Versteegen R, Rossin R, Ten Hoeve W, Janssen H, Robillard M . Click to release: instantaneous doxorubicin elimination upon tetrazine ligation. Angew Chem Int Ed Engl. 2013; 52(52):14112-6. DOI: 10.1002/anie.201305969. View

14.

Karmani L, Leveque P, Bouzin C, Bol A, Dieu M, Walrand S . Biodistribution of (125)I-labeled anti-endoglin antibody using SPECT/CT imaging: Impact of in vivo deiodination on tumor accumulation in mice. Nucl Med Biol. 2016; 43(7):415-23. DOI: 10.1016/j.nucmedbio.2016.03.007. View

15.

Herth M, Barz M, Moderegger D, Allmeroth M, Jahn M, Thews O . Radioactive labeling of defined HPMA-based polymeric structures using [18F]FETos for in vivo imaging by positron emission tomography. Biomacromolecules. 2009; 10(7):1697-703. DOI: 10.1021/bm8014736. View

16.

Morais M, Ma M . Site-specific chelator-antibody conjugation for PET and SPECT imaging with radiometals. Drug Discov Today Technol. 2018; 30:91-104. PMC: 6291455. DOI: 10.1016/j.ddtec.2018.10.002. View

17.

Boerman O, Oyen W . Immuno-PET of cancer: a revival of antibody imaging. J Nucl Med. 2011; 52(8):1171-2. DOI: 10.2967/jnumed.111.089771. View

18.

Meyer J, Houghton J, Kozlowski P, Abdel-Atti D, Reiner T, Pillarsetty N . (18)F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels-Alder Click Chemistry. Bioconjug Chem. 2015; 27(2):298-301. PMC: 4759614. DOI: 10.1021/acs.bioconjchem.5b00504. View

19.

Ujula T, Salomaki S, Autio A, Luoto P, Tolvanen T, Lehikoinen P . 68Ga-chloride PET reveals human pancreatic adenocarcinoma xenografts in rats--comparison with FDG. Mol Imaging Biol. 2009; 12(3):259-68. PMC: 2864902. DOI: 10.1007/s11307-009-0267-3. View

20.

Zeglis B, Brand C, Abdel-Atti D, Carnazza K, Cook B, Carlin S . Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics. Mol Pharm. 2015; 12(10):3575-87. PMC: 4696756. DOI: 10.1021/acs.molpharmaceut.5b00294. View